Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Lithuania Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20182
20201
20211
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
AbbVie1
InDex Pharmaceuticals1
Merck Sharp & Dohme LLC1
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1
Odyssey Therapeutics1
Pfizer1
Spyre Therapeutics, Inc.1
Warner Chilcott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases10
Colitis, Ulcerative8
Crohn Disease2
Gastrointestinal Diseases2
Colitis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.